USANA Health Sciences (NYSE:USNA) Reaches New 12-Month Low – Here’s Why

USANA Health Sciences, Inc. (NYSE:USNA) reached a new 52-week low during trading on Tuesday . The company traded as low as $31.10 and last traded at $31.35, with a volume of 8614 shares. The stock had previously closed at $31.64.

Wall Street Analysts Forecast Growth

Several research analysts have issued reports on the stock. StockNews.com raised shares of USANA Health Sciences from a “buy” rating to a “strong-buy” rating in a report on Saturday, December 28th. DA Davidson increased their target price on USANA Health Sciences from $35.00 to $38.00 and gave the company a “neutral” rating in a report on Thursday, January 2nd.

USANA Health Sciences Price Performance

The firm has a market capitalization of $600.60 million, a P/E ratio of 11.13, a P/E/G ratio of 0.88 and a beta of 0.87. The company’s 50-day simple moving average is $35.46 and its two-hundred day simple moving average is $37.74.

Institutional Trading of USANA Health Sciences

A number of hedge funds and other institutional investors have recently modified their holdings of USNA. Exchange Traded Concepts LLC raised its holdings in USANA Health Sciences by 4.4% during the third quarter. Exchange Traded Concepts LLC now owns 7,709 shares of the company’s stock valued at $292,000 after acquiring an additional 322 shares during the period. Martingale Asset Management L P boosted its position in shares of USANA Health Sciences by 2.1% during the third quarter. Martingale Asset Management L P now owns 16,732 shares of the company’s stock worth $634,000 after acquiring an additional 340 shares during the last quarter. KBC Group NV lifted its stake in USANA Health Sciences by 96.6% in the 3rd quarter. KBC Group NV now owns 1,056 shares of the company’s stock worth $40,000 after purchasing an additional 519 shares in the last quarter. R Squared Ltd purchased a new position in shares of USANA Health Sciences during the fourth quarter valued at about $28,000. Finally, Safe Harbor Fiduciary LLC bought a new stake in shares of USANA Health Sciences in the third quarter worth about $30,000. 54.25% of the stock is owned by hedge funds and other institutional investors.

About USANA Health Sciences

USANA Health Sciences, Inc develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products.